Twenty early-career cancer researchers from around the world were selected for the 2026 AACR Global Scholar-in-Training Award (GSITA) programs.
Grab a cold drink and escape the midsummer heat with July’s rendition of Editors’ Picks. This month, the editors...
Improved patient outcomes come from new treatments. New treatments stem from successful clinical trials. Clinical trials build on discoveries...
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today The artificial intelligence (AI) revolution has important implications for...
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
According to an annual Gallup poll that surveys approximately 10,000 U.S. adults, 7.2% of Americans aged 18 and older...
As we head into summer, enjoy this month’s selection of studies spotlighted by the editors of the 10 AACR...
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...
The milieu of cells, proteins, and vasculature that comprise the tumor microenvironment can hinder efforts to treat cancer. This...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...